🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering products of uncertain source.

Several professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or prison.

Service Reaction and Content Removal

Based on TikTok, the platform has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Information and Costs

Within these communities, messages display black plastic parcels with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious health risks”.